EMD Serono, Inc.
EMD Website

Partnering with Us

 
 


Success Through Partnerships
At EMD Serono, Inc. we are committed to success through partnerships. We achieve this through dedicated alliance managers, joint project teams, a governance structure facilitating decision-making, open communications and an unfailing pursuit of common goals. That commitment, and our ability to deliver on it, makes EMD Serono the partner of choice.
Partnering with other biotechnology and pharmaceutical companies, as well as leading academic institutions, is a core part of our strategy. By combining complementary expertise and resources, we create an environment that enables us to enhance value and move our projects forward. This helps us to bring therapeutic innovations to patients more quickly.
EMD Serono is an affiliate Merck KGaA, Darmstadt, Germany. Along with Merck Serono, as the division is known outside of North America, we offer potential partners a solid foundation upon which to build mutually rewarding relationships.
Here is a listing of key partnerships with Merck KGaA, and its affiliates Merck Serono and EMD Serono, Inc.:
 
 
Global Partnerships
Ablynx Ecole Polytechnique Federal de Lausanne (EPFL) Oncothyreon
Ambrx Edeiras OSI (US only)
Analyticon Discovery Eidgenossische Technische Hochschule (ETH) Zurich Paratek
Angiosyn Flamel Pfizer (US only)
Apitope Forrest Pharmaceuticals Pasteur Institute
Archemix Emmaus Regeneron
Aurigene Fast Forward (US only) Rigel
Biomarin Genfit Scripps Research Institute
Bionomics Hutchinson/Chi-Med SRD Pharmaceuticals
BioVascular Idera Taiho Pharmaceuticals
Bristol-Myers Squibb (BMS) Imclone (Eli Lilly) Tanabe
Celgene KineMed TargeGene
Cenix Bioscience Lpath Theratechnologies (US only)
ChemDiv Micromet Tioga
Clinical Data, Inc. Max Planck Institute University of Dundee/Academic Consortium
CuraScript, Inc. Newron Weizmann Institute of Science
Daninippon Sumitomo Nippon Shinyaku ZymoGenetics
Dyax Ocimum Biosolution

CONTACT US

Steven Axon
For more information about opportunities for collaboration at EMD Serono, Inc., contact Steven Axon, Vice President, Head of Business Development U.S.A. Head of Global Business Development, Endocrinology/Fertility

SERVICES